Clinical Trial Update: BOLD MRI and FMISO PET for the Assessment of Hypoxic Tumor Microenvironment in Patients with Oligometastatic Liver Cancer Undergoing Yttirum-90 Selective Internal Radiation Therapy [EARLY_Phase 1]

View source ↗

Summary

This early-phase study evaluated imaging approaches (BOLD MRI and FMISO PET) to assess the hypoxic tumor microenvironment in patients with hepatocellular carcin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Yttrium-90 microspheres (yttrium-90 microspheres)

Snippet

Sponsor: Emory University | Conditions: BCLC Stage a Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma | EARLY_Phase 1 | Status: COMPLETED